Actavia Life Sciences Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2014 - 2018
Period Ending	Dec '25 Dec 24, 2025	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020	Sep '19 Sep 30, 2019	2014 - 2018
Market Capitalization	0	15	2	4	5	10	Upgrade
Market Cap Growth	-99.85%	603.00%	-46.89%	-20.00%	-50.00%	-68.75%	Upgrade
Enterprise Value	-	16	2	5	6	11	Upgrade
Last Close Price	0.00	0.02	0.01	0.06	0.07	0.15	Upgrade
PB Ratio	-0.18	-7.89	-1.30	-1.50	-1.93	4.07	Upgrade
Debt / Equity Ratio	-0.14	-0.11	-0.13	-0.25	-0.19	0.10	Upgrade
Quick Ratio	0.00	0.04	0.02	0.00	0.01	0.02	Upgrade
Current Ratio	0.02	0.05	0.05	0.02	0.01	0.03	Upgrade
Return on Equity (ROE)	-	-	-	-	-	-33.19%	Upgrade
Return on Assets (ROA)	-427.68%	-2928.18%	-369.57%	-399.60%	-13.97%	-11.25%	Upgrade
Return on Capital Employed (ROCE)	15.80%	216.70%	24.00%	9.00%	20.80%	-36.10%	Upgrade
Earnings Yield	-105.37%	-28.78%	-31.27%	-21.19%	-103.46%	-9.06%	Upgrade
FCF Yield	-	-0.06%	-14.24%	-7.10%	-4.86%	-0.90%	Upgrade
Buyback Yield / Dilution	-186.81%	-418.75%	-61.70%	-	-	-	Upgrade

Updated May 20, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.